STOCK TITAN

electroCore to Announce Third Quarter 2022 Financial Results on November 3

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) will release its third quarter financial results on November 3, 2022, after market hours. A conference call and webcast will follow at 4:30 PM EDT to discuss the results. The company focuses on bioelectronic medicine, utilizing non-invasive vagus nerve stimulation therapy for treating various neurological conditions, including migraines and cluster headaches.

Positive
  • Focused on neurological conditions with a non-invasive treatment approach.
  • Potential for growth in multiple treatment indications.
Negative
  • None.

ROCKAWAY, N.J., Oct. 27, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the third quarter ended September 30, 2022, after the close of the market on Thursday, November 3, 2022. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.

Thursday, November 3, 2022, 4:30 PM EDT
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13733010
Webcast: electroCore Earnings Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

Contact:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital


FAQ

What are the financial results for electroCore for Q3 2022?

electroCore will report its financial results for Q3 2022 on November 3, 2022.

When will electroCore's earnings conference call occur?

The earnings conference call will be held on November 3, 2022, at 4:30 PM EDT.

What is the ticker symbol of electroCore?

The ticker symbol for electroCore is ECOR.

What conditions does electroCore's therapy target?

electroCore's therapy targets conditions like cluster headache and migraine.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

106.58M
4.91M
25.02%
16.11%
0.67%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY